Meet Ubonrat Thaonoi, the TV anchor recruited to save government’s image
Thailand Moves to Advance AI-Powered Cancer Diagnosis
Keeping pace with HIV/Aids
AI In-Brief
Thailand News in Brief
Thai PBS World
Thailand and the world, every day
AI can make mistakes. Please double-check.
AI In-brief11 Sept 02:02
Keeping pace with HIV/Aids
Despite significant advancements, HIV/AIDS remains widely misunderstood, contributing to stigma and discrimination, as recently underscored by a scandal involving a temple exploiting patients for funds.
Experts emphasize that HIV is treatable and preventable; antiretroviral (ARV) medications can suppress the virus to undetectable levels, preventing transmission and allowing individuals to lead normal, healthy lives.
Thailand provides comprehensive, free HIV treatment and prevention services, including ARV therapy, PrEP, and self-test kits, under its Universal Health Coverage Scheme, yet stigma continues to hinder testing and treatment uptake.
National goals aim to drastically reduce new HIV infections, deaths, and discrimination by 2030, urging widespread testing, continuous public education, and supportive environments to combat the disease effectively.
AI In-briefYesterday 19:58
Thailand Moves to Advance AI-Powered Cancer Diagnosis
Thailand's Royal College of Pathologists and Thai Society of Clinical Oncology are collaborating to establish guidelines for integrating AI into oncology pathology, aiming for faster and more accurate cancer diagnoses.
AI is positioned to address critical challenges, including a severe shortage of pathologists (approximately 500 for 140,000 new cancer cases annually) and the escalating demand for precision oncology, which currently strains existing healthcare services.
A strategic plan for nationwide AI adoption encompasses strengthening pathologists' AI skills, developing a national digital pathology repository, establishing reimbursement standards, and creating regulatory frameworks to ensure safe, ethical, and equitable access.
Experts emphasize that AI will serve as a crucial assistive tool, enhancing human pathologists' capabilities in diagnostic precision and treatment decisions, rather than replacing essential human oversight.